June 2018
IIVS e-News – June 2018
June 26, 2018In this issue, find out the dates for the 2019 Practical Methods Workshop and the PISC award for young scientists, learn about upcoming In Vitro-related meetings and extended deadlines for abstract submission, read recent IIVS publications, and more. Read issue....
Abstract Deadline Extended for EUSAAT 2018
June 21, 2018The 21st European Congress on Alternatives to Animal Testing & 18th Annual Congress of EUSAAT (European Society for Alternatives to Animal Testing) will take place in Linz, Austria, 23-26 September. Submission deadlines for both oral and poster presentations have been extended to July 6. Erin Hill and Rodger Curren from IIVS are both speaking at the event. Learn more about the meeting, including the scientific program, invited speakers, and how to register. ...
Next-Generation Tobacco and Nicotine Products: Substantiating Harm Reduction and Supporting Tobacco Regulatory Science
June 21, 2018A framework for the assessment of novel next-generation tobacco and nicotine products with the potential to reduce health risks compared with cigarettes should integrate scientific studies incorporating nonclinical, clinical, and population studies approaches. These products should have lower emissions and exhibit reduced biological effects compared with those of cigarettes, ideally approaching those of smoking cessation. The products should also be acceptable cigarette alternatives for current smokers, while not appealing to nonsmokers or former smokers. Validating harm reduction and promoting regulatory acceptance...
Characterization of a Vitrocell VC1 Using Nicotine Dosimetry: An Essential Component Toward Standardized In Vitro Aerosol Exposure of Tobacco and Next Generation Nicotine Delivery Products
June 21, 2018The U.S. Food and Drug Administration has regulatory authority over tobacco products, including conventional cigarettes and next generation products (NGPs) such as e-cigarettes and tobacco heating products (THPs). There is a desire by the industry, regulators and animal protection organizations to incorporate non-animal test methods for tobacco product and NGP assessment. When assessing respiratory effects in vitro, reliable exposure systems that deliver aerosols to cellular/tissue cultures (such as human reconstructed airways or lung slices) at the air–liquid interface are needed. Using nicotine dosimetry, we report the...
Quality Assurance Associate
June 20, 2018We are seeking a full time Quality Assurance Associate to work in our Gaithersburg office. This is an exciting opportunity to join and grow with our team to contribute and share in our company vision: A day when methods based on humane, wisely applied science will be used by industry and the regulatory agencies to understand the true safety and efficacy of substances. The Quality Assurance Associate is asked to participate in the Quality Assurance monitoring and Good Laboratory Practice auditing...
Abstract Deadline Extended for ESTIV 2018
June 18, 2018The 20th International Congress on In Vitro Toxicology (ESTIV2018) happening in Berlin, 15-18 October, has extended their abstract submission deadline to July 1. Several grants and bursaries are also still open to applicants until July 1, including the PETA International Science Consortium early-career scientist award. Learn more about the meeting, including the scientific program, invited speakers, and how to register. ...
Holger Behrsing, PhD, Participates in Round Table Discussion on Non-Animal Approaches for Inhalation Toxicology
June 14, 2018Holger Behrsing, PhD, was recently invited to participate in an expert round table discussion convened on the development and implementation of 21st century non-animal approaches to assess the toxicity of inhaled substances. The discussion included perspectives from government, industry, nonprofit, and academic sectors on the advantages and challenges of using these approaches, ongoing efforts, and steps needed to gain widespread use and acceptance of these approaches. A transcript of the discussion has just been published in Applied In Vitro Toxicology, Vol....
Client Services Representative
June 8, 2018We are seeking a full time Client Services Representative to work in our Gaithersburg office. This is an exciting opportunity to join and grow with our team to contribute and share in our company vision: A day when methods based on humane, wisely applied science will be used by industry and the regulatory agencies to understand the true safety and efficacy of substances. Looking for a highly motivated, organized, and detail oriented person to serve as primary liaison between the Institute...
IIVS at EuroTox 2018
June 7, 2018IIVS President, Erin Hill, and Business Development Manager, Brent Gilbert, will be at the upcoming EuroTox 2018 in Brussels on September 3-5. Stop by our booth (#55) to chat with us or contact us to set up a meeting. In addition, IIVS will be presenting two posters. Text to be added. ...
Cruelty-Free Cosmetics Act Passes in California Senate.
June 1, 2018Yesterday, the California Senate passed the California Cruelty-Free Cosmetics Act (SB1249) bringing the state one step closer to becoming the first state in the U.S. to ban the sale of animal-tested cosmetics. The bill will now move on to the Assembly. If passed, SB1249 will outlaw the sale of all animal-tested cosmetics (including makeup, hair and skin care, and personal hygiene products) by 2020. Read more....